Restored thyroid receptor makes aggressive tumors more vulnerable to CAR-T cell therapy

Mayo Clinic researchers have identified a strategy that could help chimeric antigen receptor-T cell therapy, or CAR-T cell therapy, overcome a major barrier to treating solid tumors: Cancer cells can change in ways that allow them to hide from immune cells designed to attack them.

Read it at Medical Xpress ↗

← Front page